{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:20:42Z","timestamp":1787952042106,"version":"build-2784847793"},"reference-count":53,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN143313"],"award-info":[{"award-number":["FDN143313"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003498","name":"Women's College Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003498","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000028","name":"Institute of Circulatory and Respiratory Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030898","name":"Institut canadien d'information sur la sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012665","name":"Institute for Clinical Evaluative Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.hrthm.2025.05.040","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T19:28:34Z","timestamp":1747942114000},"page":"e849-e857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["East Asian immigration and direct oral anticoagulant dosing for atrial fibrillation: A population-based cohort study"],"prefix":"10.1016","volume":"22","author":[{"given":"Erika","family":"Nakajima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.T.","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Jackevicius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis T.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Dorian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7105-7931","authenticated-orcid":false,"given":"Husam","family":"Abdel-Qadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2025.05.040_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.05.040_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2025.05.040_bib3","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.05.040_bib4","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.05.040_bib5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.05.040_bib6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.05.040_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.007971","article-title":"Off-label under- and overdosing of direct oral anticoagulants in patients with atrial fibrillation: a meta-analysis","volume":"14","author":"Zhang","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.hrthm.2025.05.040_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijcard.2022.04.062","article-title":"Clinical effects of off-label reduced doses of Direct Oral anticoagulants: a systematic review and meta-analysis","volume":"362","author":"Pereira","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2025.05.040_bib9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s10557-019-06910-z","article-title":"Real-world comparisons of direct oral anticoagulants for stroke prevention in Asian patients with non-valvular atrial fibrillation: a systematic review and meta-analysis","volume":"33","author":"Chan","year":"2019","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.hrthm.2025.05.040_bib10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijcard.2022.09.073","article-title":"Off-label dose direct oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation: a new evidence of Asian dose","volume":"371","author":"Xu","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2025.05.040_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.chest.2019.04.108","article-title":"Effectiveness and safety of four direct oral anticoagulants in Asian patients with nonvalvular atrial fibrillation","volume":"156","author":"Chan","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.hrthm.2025.05.040_bib12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.amjcard.2020.09.053","article-title":"Dose of direct oral anticoagulants and adverse outcomes in Asia","volume":"139","author":"Ohno","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2025.05.040_bib13","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.15420\/ecr.2020.43","article-title":"Direct oral anticoagulants in Asian patients with atrial fibrillation: consensus recommendations by the Asian Pacific Society of cardiology on strategies for thrombotic and bleeding risk management","volume":"16","author":"Chong","year":"2021","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.hrthm.2025.05.040_bib14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1253\/circj.CJ-18-0991","article-title":"Clinical outcomes of off-label dosing of direct oral anticoagulant therapy among Japanese patients with atrial fibrillation identified from the SAKURA AF registry","volume":"83","author":"Murata","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2025.05.040_bib15","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/STROKEAHA.120.029295","article-title":"Adherence to anticoagulant guideline for atrial fibrillation improves outcomes in Asian population: the COOL-AF registry","volume":"51","author":"Krittayaphong","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.hrthm.2025.05.040_bib16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.clpt.2004.05.005","article-title":"Novel CYP2C9 genetic variants in Asian subjects and their influence on maintenance warfarin dose","volume":"76","author":"Zhao","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.hrthm.2025.05.040_bib17","article-title":"Ethnic differences in body composition and obesity-related risk factors: study in Chinese and white males living in China","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.hrthm.2025.05.040_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0008-6215(91)80130-F","article-title":"Sulfation of some chemically modified heparins. Formation of a 3-sulfate analog of heparin","volume":"210","author":"Rej","year":"1991","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.hrthm.2025.05.040_bib19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jacc.2007.01.098","article-title":"Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation","volume":"50","author":"Shen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.05.040_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2133\/dmpk.DMPK-12-RG-034","article-title":"Model-based dose selection for phase III Rivaroxaban study in Japanese patients with non-valvular atrial fibrillation","volume":"28","author":"Tanigawa","year":"2013","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.hrthm.2025.05.040_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2133\/dmpk.DMPK-12-RG-109","article-title":"Confirmation of model-based dose selection for a Japanese phase III study of Rivaroxaban in non-valvular atrial fibrillation patients","volume":"28","author":"Kaneko","year":"2013","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.hrthm.2025.05.040_bib22","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1253\/circj.CJ-20-1212","article-title":"JCS\/JHRS 2020 guideline on pharmacotherapy of cardiac arrhythmias","volume":"86","author":"Ono","year":"2022","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2025.05.040_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013053","article-title":"Comparisons of Rivaroxaban following different dosage criteria (ROCKET AF or J-ROCKET AF trials) in Asian patients with atrial fibrillation","volume":"8","author":"Chan","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2025.05.040_bib24","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.4070\/kcj.2018.0339","article-title":"Korean guideline of atrial fibrillation management","volume":"48","author":"Joung","year":"2018","journal-title":"Korean Circ J"},{"key":"10.1016\/j.hrthm.2025.05.040_bib25","author":"Canada"},{"key":"10.1016\/j.hrthm.2025.05.040_bib26","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/CIRCULATIONAHA.115.015345","article-title":"The incidence of major cardiovascular events in immigrants to Ontario, Canada: the CANHEART immigrant study","volume":"132","author":"Tu","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2025.05.040_bib27","first-page":"67","article-title":"Coding accuracy of administrative drug claims in the Ontario Drug Benefit database","volume":"10","author":"Levy","year":"2003","journal-title":"Can J Clin Pharmacol"},{"key":"10.1016\/j.hrthm.2025.05.040_bib54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12911-016-0375-3","article-title":"Describing the linkages of the immigration, refugees and citizenship Canada permanent resident data and vital statistics death registry to Ontario\u2018s administrative health database","volume":"16","author":"Chiu","year":"2016","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.hrthm.2025.05.040_bib28","doi-asserted-by":"crossref","first-page":"E121","DOI":"10.1503\/cmaj.121218","article-title":"Rates of hemorrhage during warfarin therapy for atrial fibrillation","volume":"185","author":"Gomes","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/j.hrthm.2025.05.040_bib29","first-page":"1561","article-title":"Identifying patients with atrial fibrillation in administrative data","volume":"32","author":"Tu","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hrthm.2025.05.040_bib30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1017\/cjn.2016.278","article-title":"Accuracy of administrative data for the coding of acute stroke and TIAs","volume":"43","author":"Hall","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.hrthm.2025.05.040_bib31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.12927\/hcq.2018.25630","article-title":"Integrating population-wide laboratory testing data with audit and feedback reports for Ontario physicians","volume":"21","author":"Campitelli","year":"2018","journal-title":"Healthc Q"},{"key":"10.1016\/j.hrthm.2025.05.040_bib32","first-page":"1135","article-title":"ICES: data, discovery, better health","volume":"4","author":"Schull","year":"2020","journal-title":"Int J Popul Data Sci"},{"key":"10.1016\/j.hrthm.2025.05.040_bib34","first-page":"e85","article-title":"Classification of Canadian immigrants into visible minority groups using country of birth and mother tongue","volume":"7","author":"Rezai","year":"2013","journal-title":"Open Med"},{"key":"10.1016\/j.hrthm.2025.05.040_bib35","first-page":"1847","article-title":"The 2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation","volume":"36","author":"Andrade","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hrthm.2025.05.040_bib36","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(18)30668-8","article-title":"Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study","volume":"391","author":"Gilbert","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2025.05.040_bib37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A new risk scheme to predict warfarin-associated hemorrhage","volume":"58","author":"Fang","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.05.040_bib38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.hrthm.2025.05.040_bib39","first-page":"1322","article-title":"Missing data in clinical research: a tutorial on multiple imputation","volume":"37","author":"Austin","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hrthm.2025.05.040_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211061148","article-title":"What is Standard Dose of Rivaroxaban in Elderly Asian Patients with atrial fibrillation: 20ms versus. 15mg?","volume":"27","author":"Kim","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.hrthm.2025.05.040_bib41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3349\/ymj.2019.60.3.277","article-title":"Label adherence for non-vitamin K antagonist oral anticoagulants in a prospective cohort of Asian patients with atrial fibrillation","volume":"60","author":"Lee","year":"2019","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.hrthm.2025.05.040_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102039","article-title":"Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the Gloria-AF Registry","volume":"63","author":"Romiti","year":"2023","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.hrthm.2025.05.040_bib43","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/j.hrthm.2020.07.022","article-title":"Off-label dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation","volume":"17","author":"Chan","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2025.05.040_bib44","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.jacc.2016.09.966","article-title":"Off-label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes: the ORBIT-AF II registry","volume":"68","author":"Steinberg","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.05.040_bib45","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014177","article-title":"Label adherence of direct oral anticoagulants dosing and clinical outcomes in patients with atrial fibrillation","volume":"9","author":"Yu","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2025.05.040_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008150","article-title":"Efficacy and safety of Apixaban, dabigatran, Rivaroxaban, and warfarin in Asians with nonvalvular atrial fibrillation","volume":"7","author":"Chan","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2025.05.040_bib47","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1161\/STROKEAHA.118.024210","article-title":"Optimal Rivaroxaban dose in Asian patients with atrial fibrillation and normal or mildly impaired renal function","volume":"50","author":"Lee","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.hrthm.2025.05.040_bib48","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1038\/s41598-018-21884-y","article-title":"Effectiveness and safety of different Rivaroxaban dosage regimens in patients with non-valvular atrial fibrillation: A nationwide, population-based cohort study","volume":"8","author":"Huang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.hrthm.2025.05.040_bib49","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1161\/STROKEAHA.115.009947","article-title":"Non-vitamin K antagonist oral anticoagulants for stroke prevention in Asian patients with nonvalvular atrial fibrillation: meta-analysis","volume":"46","author":"Wang","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.hrthm.2025.05.040_bib50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40264-024-01476-8","article-title":"Comparative effectiveness and safety of off-label underdosed direct oral anticoagulants in Asian patients with atrial fibrillation: a systematic review and meta-analysis","volume":"48","author":"Mongkhon","year":"2025","journal-title":"Drug Saf"},{"key":"10.1016\/j.hrthm.2025.05.040_bib51","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cardfail.2019.03.006","article-title":"Incidence of heart failure among immigrants to Ontario, Canada: a CANHEART immigrant study","volume":"25","author":"Di Giuseppe","year":"2019","journal-title":"J Card Fail"},{"key":"10.1016\/j.hrthm.2025.05.040_bib52","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.05.040_bib53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s40262-016-0434-z","article-title":"Discrepancies between the Cockcroft-Gault and chronic kidney disease epidemiology (CKD-EPI) equations: implications for refining drug dosage adjustment strategies","volume":"56","author":"Delanaye","year":"2017","journal-title":"Clin Pharmacokinet"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527125025007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527125025007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:31:57Z","timestamp":1778617917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527125025007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1547527125025007"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.05.040","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"East Asian immigration and direct oral anticoagulant dosing for atrial fibrillation: A population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.05.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Heart Rhythm Society. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}